pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Private Biotech · news · pharmadog
← back to Private Biotech
News · Private Biotech
16
stories
5d
Deep-pocketed Verdiva axes GLP-1 switching trial over ‘market evolution’
fiercebiotech
6d
Verdiva cans mid-stage obesity trial of GLP-1 pill, citing 'market evolution'
endpoints
10d
This week in charts: What’s driving biotech’s recent pullback?
biopharma dive
28d
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
biospace
Sep 17, 26
North Immunology goes public via reverse merger as eczema drug heads toward clinic
fiercebiotech
Sep 10, 26
A booming business on Wall Street would love more biotechs to quietly die
biopharma dive
Aug 10, 26
Jazz to buy rare epilepsy drugmaker in potentially $1.3B deal
biopharma dive
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
Jul 6, 26
Cancer, immune drugmakers dominate VC funding so far in 2026
biopharma dive
Jul 1, 26
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
stat
Jul 1, 26
A June flourish lifts biotech megaround tally in first half of 2026
endpoints
Jun 30, 26
Nominations are open for the 2026 Endpoints 11 awards
endpoints
Jun 18, 26
Kardigan extends biotech’s streak of big IPOs with $400M haul
biopharma dive
Jun 10, 26
Parabilis sets a record with a $670M biotech IPO
biopharma dive
Jun 2, 26
Anti-aging biotech NewLimit raises $435M at $3B+ valuation
endpoints
May 12, 26
Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech
endpoints
